DOCS - Company ID 0001516513
The table below shows Doximity, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $185.05M | $168.53M | $145.91M | $168.60M | $136.83M | $126.68M |
| Cost of revenue | $18.70M | $16.43M | $15.79M | $14.18M | $13.68M | $13.55M |
| Gross profit | $166.35M | $152.10M | $130.12M | $154.42M | $123.16M | $113.13M |
| R&D | $34.59M | $30.20M | $26.80M | $22.42M | $23.24M | $22.57M |
Doximity, Inc. reported annual revenue of $644.86M for fiscal year 2026. That is up 13.1% from $570.40M in fiscal 2025. Over the 7 fiscal years shown, annual revenue grew from $116.39M (FY 2020) to $644.86M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $17.66M | $19.05M | $12.44M | $13.59M | $10.10M | $9.26M |
| Operating income | $71.90M | $63.68M | $54.52M | $79.92M | $53.14M | $46.05M |
| Income tax | $19.24M | $10.88M | $10.83M | $14.64M | $18.02M | $11.79M |
| Net income | $61.56M | $62.06M | $53.32M | $75.20M | $44.15M | $41.38M |
| EPS (diluted) | $0.31 | $0.31 | $0.27 | $0.37 | $0.22 | $0.21 |